Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

66
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
66
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

68
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
68
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

45
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
45

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prediction of axillary lymph node metastasis using a transformer model and multi-omics validation in breast cancer.

NPJ precision oncology·2026
Same author

Achieving Advanced Performance: Progress and Prospects on Non-Traditional Rechargeable Zinc-Air Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized Patients With Inflammatory Bowel Disease.

Journal of clinical gastroenterology·2026
Same author

Antibiotics for Uncomplicated Acute Appendicitis.

JAMA·2026
Same author

Multifunctional bacterial consortium degrading phthalates, promoting plant growth and inhibiting soil-borne pathogenic fungi.

Journal of hazardous materials·2026
Same author

The Influence of M1 and DLPFC iTBS on BCI Performance: A TMS and fNIRS Study.

Translational stroke research·2026

相关实验视频

Updated: Jun 12, 2025

A Mouse Model of Intestinal Partial Obstruction
07:33

A Mouse Model of Intestinal Partial Obstruction

Published on: March 5, 2018

21.1K

酸性胃肠炎引起的肠道阻塞.

Cong Dai1, Yu-Hong Huang2

  • 1Gastroenterology, First Affiliated Hospital. China Medical University, china.

Revista espanola de enfermedades digestivas
|September 19, 2024
PubMed
概括

酸性胃肠炎在一个病人身上引起了肠道阻塞. 用普得尼松治疗缓解了症状,突出了它在治疗这种罕见的胃肠道疾病方面的有效性.

科学领域:

  • 胃肠病学 胃肠病学
  • 内部医学 内部医学
  • 病理学 病理学 病理学

背景情况:

  • 生性胃肠炎 (EG) 是一种罕见的胃肠道疾病,其特征是肠道的生性透.
  • 症状可能是不特定的,包括腹痛,张,吐和体重减轻,通常模仿其他疾病.
  • 肠道阻塞是EG的不太常见但严重的并发症.

研究的目的:

  • 为了呈现一种带有肠道阻塞的eosinophilic胃肠炎病例.
  • 突出诊断挑战和成功管理这种情况.

主要方法:

  • 一名53岁的男性患者出现了腹痛和腹张的症状.
  • 诊断工作包括实验室检测 (乙氨基酸,IgE,CRP的升高),成像 (腹部CT),内镜 (胃镜,双气球肠镜,结肠镜) 和组织病理学.
  • 治疗涉及口服普雷尼松.

主要成果:

  • 实验室发现显示显著的eosinophilia和升高的IgE.
  • 腹部CT显示了扩散的肠壁加厚和扩张,暗示了阻塞.
  • 组织病理学证实显著的eosinophilic透在胃和小肠粘膜.
  • 患者经历了完整的症状缓解在三周的普得尼松治疗.

更多相关视频

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

684
Postoperative Ileus Murine Model
04:26

Postoperative Ileus Murine Model

Published on: July 12, 2024

543

相关实验视频

Last Updated: Jun 12, 2025

A Mouse Model of Intestinal Partial Obstruction
07:33

A Mouse Model of Intestinal Partial Obstruction

Published on: March 5, 2018

21.1K
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

684
Postoperative Ileus Murine Model
04:26

Postoperative Ileus Murine Model

Published on: July 12, 2024

543

结论:

  • 异性胃肠炎可能导致肠道阻塞.
  • 通过临床表现,成像和活检的结合即时诊断至关重要.
  • 皮质类固醇治疗,如普雷尼松,是有效的管理eosinophilic胃肠炎及其并发症.